US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-Malarial Drug market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-Malarial Drug market." Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection. On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region The global Anti-Malarial Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Anti-Malarial Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Malarial Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: GlaxoSmithKline Ranbaxy Zydus Cadila Alvizia Bayer Ipca Merck F. Hoffmann-La Roche Novartis Pfizer Segment by Regions North America Europe China Japan Segment by Type By meterial Plasmodium Falciparum Plasmodium Vivax Plasmodium Malariae Plasmodium Ovale By mechanism of action Resistance Prevention Segment by Application Hospital Pharmacy Retail Pharmacy E-Commerce Others
Table of Contents Executive Summary 1 Anti-Malarial Drug Market Overview 1.1 Product Overview and Scope of Anti-Malarial Drug 1.2 Anti-Malarial Drug Segment By meterial 1.2.1 Global Anti-Malarial Drug Production Growth Rate Comparison By meterial (2014-2025) 1.2.2 Plasmodium Falciparum 1.2.3 Plasmodium Vivax 1.2.4 Plasmodium Malariae 1.2.5 Plasmodium Ovale 1.3 Anti-Malarial Drug Segment by Application 1.3.1 Anti-Malarial Drug Consumption Comparison by Application (2014-2025) 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 E-Commerce 1.3.5 Others 1.4 Global Anti-Malarial Drug Market by Region 1.4.1 Global Anti-Malarial Drug Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Anti-Malarial Drug Market Size 1.5.1 Global Anti-Malarial Drug Revenue (2014-2025) 1.5.2 Global Anti-Malarial Drug Production (2014-2025) 2 Global Anti-Malarial Drug Market Competition by Manufacturers 2.1 Global Anti-Malarial Drug Production Market Share by Manufacturers (2014-2019) 2.2 Global Anti-Malarial Drug Revenue Share by Manufacturers (2014-2019) 2.3 Global Anti-Malarial Drug Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Anti-Malarial Drug Production Sites, Area Served, Product Types 2.5 Anti-Malarial Drug Market Competitive Situation and Trends 2.5.1 Anti-Malarial Drug Market Concentration Rate 2.5.2 Anti-Malarial Drug Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Anti-Malarial Drug Production Market Share by Regions 3.1 Global Anti-Malarial Drug Production Market Share by Regions 3.2 Global Anti-Malarial Drug Revenue Market Share by Regions (2014-2019) 3.3 Global Anti-Malarial Drug Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Anti-Malarial Drug Production 3.4.1 North America Anti-Malarial Drug Production Growth Rate (2014-2019) ... | read more...